Variant report
Variant | esv3371250 |
---|---|
Chromosome Location | chr2:74010144-74014742 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:115)
- CpG islands (count:244)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | BATF | chr2:74012103-74012308 | GM12878 | blood: | n/a | n/a |
2 | BATF | chr2:74012316-74012516 | GM12878 | blood: | n/a | n/a |
3 | BATF | chr2:74011334-74011570 | GM12878 | blood: | n/a | n/a |
4 | BATF | chr2:74011141-74011519 | GM12878 | blood: | n/a | n/a |
5 | BCL11A | chr2:74012160-74012430 | GM12878 | blood: | n/a | n/a |
6 | BCL11A | chr2:74011201-74011579 | GM12878 | blood: | n/a | n/a |
7 | EBF1 | chr2:74011309-74011503 | GM12878 | blood: | n/a | n/a |
8 | EBF1 | chr2:74011106-74011300 | GM12878 | blood: | n/a | n/a |
9 | EBF1 | chr2:74011089-74011368 | GM12878 | blood: | n/a | n/a |
10 | EP300 | chr2:74011089-74011596 | GM12878 | blood: | n/a | n/a |
11 | EP300 | chr2:74012043-74012498 | GM12878 | blood: | n/a | n/a |
12 | EP300 | chr2:74012713-74013007 | GM12878 | blood: | n/a | n/a |
13 | EP300 | chr2:74012244-74012413 | GM12878 | blood: | n/a | n/a |
14 | EP300 | chr2:74013651-74013822 | GM12878 | blood: | n/a | n/a |
15 | FOS | chr2:74010743-74010860 | MCF10A-Er-Src | breast: | n/a | n/a |
16 | FOS | chr2:74010741-74010932 | MCF10A-Er-Src | breast: | n/a | n/a |
17 | FOS | chr2:74010730-74010950 | MCF10A-Er-Src | breast: | n/a | n/a |
18 | FOS | chr2:74010732-74010941 | MCF10A-Er-Src | breast: | n/a | n/a |
19 | FOSL2 | chr2:74014735-74015333 | HepG2 | liver: | n/a | n/a |
20 | FOSL2 | chr2:74012176-74012583 | HepG2 | liver: | n/a | n/a |
21 | FOSL2 | chr2:74011035-74011538 | HepG2 | liver: | n/a | chr2:74011302-74011311 |
22 | FOSL2 | chr2:74013496-74013820 | HepG2 | liver: | n/a | chr2:74013777-74013785 |
23 | FOSL2 | chr2:74011099-74011599 | HepG2 | liver: | n/a | chr2:74011302-74011311 |
24 | FOSL2 | chr2:74012130-74012364 | HepG2 | liver: | n/a | n/a |
25 | FOSL2 | chr2:74010378-74010865 | A549 | lung: | n/a | chr2:74010778-74010789 |
26 | FOSL2 | chr2:74010457-74011032 | HepG2 | liver: | n/a | chr2:74010778-74010789 |
27 | FOSL2 | chr2:74010094-74010934 | HepG2 | liver: | n/a | chr2:74010778-74010789 |
28 | FOSL2 | chr2:74013880-74014300 | HepG2 | liver: | n/a | n/a |
29 | FOXA1 | chr2:74011987-74012292 | HepG2 | liver: | n/a | n/a |
30 | GATA2 | chr2:74011256-74011486 | K562 | blood: | n/a | n/a |
31 | GATA2 | chr2:74011948-74012198 | K562 | blood: | n/a | n/a |
32 | GATA2 | chr2:74012293-74012539 | K562 | blood: | n/a | n/a |
33 | HEY1 | chr2:74011085-74011554 | K562 | blood: | n/a | n/a |
34 | HEY1 | chr2:74010441-74010908 | HepG2 | liver: | n/a | n/a |
35 | IRF4 | chr2:74011089-74011481 | GM12878 | blood: | n/a | n/a |
36 | IRF4 | chr2:74011725-74012298 | GM12878 | blood: | n/a | n/a |
37 | IRF4 | chr2:74012097-74012561 | GM12878 | blood: | n/a | n/a |
38 | IRF4 | chr2:74011087-74011586 | GM12878 | blood: | n/a | n/a |
39 | IRF4 | chr2:74013541-74013856 | GM12878 | blood: | n/a | n/a |
40 | JUND | chr2:74010575-74010877 | HepG2 | liver: | n/a | chr2:74010779-74010790 |
41 | JUND | chr2:74010496-74010969 | HepG2 | liver: | n/a | chr2:74010779-74010790 |
42 | JUND | chr2:74012038-74012356 | HepG2 | liver: | n/a | n/a |
43 | JUND | chr2:74011081-74011507 | HepG2 | liver: | n/a | chr2:74011302-74011311 |
44 | JUND | chr2:74011343-74011518 | HepG2 | liver: | n/a | n/a |
45 | JUND | chr2:74010652-74010854 | HepG2 | liver: | n/a | chr2:74010779-74010790 |
46 | MAFF | chr2:74010769-74010774 | HepG2 | liver: | n/a | n/a |
47 | MAX | chr2:74010528-74010863 | A549 | lung: | n/a | n/a |
48 | MAX | chr2:74010379-74010877 | A549 | lung: | n/a | n/a |
49 | NFIC | chr2:74011589-74011944 | GM12878 | blood: | n/a | n/a |
50 | PAX5 | chr2:74012236-74012395 | GM12878 | blood: | n/a | n/a |
No. | Chromosome Location | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr2:74010396-74010446 | HL-60 | blood: | n/a |
2 | chr2:74010290-74010340 | ECC-1 | luminal epithelium: | n/a |
3 | chr2:74010290-74010340 | Hela-S3 | cervix: | n/a |
4 | chr2:74010621-74010671 | A549 | lung: | n/a |
5 | chr2:74010290-74010340 | SK-N-SH_RA | brain: | n/a |
6 | chr2:74010290-74010340 | AG10803 | skin: | n/a |
7 | chr2:74010554-74010604 | SK-N-SH | brain: | n/a |
8 | chr2:74010290-74010340 | SK-N-SH | brain: | n/a |
9 | chr2:74010554-74010604 | HMEC | breast: | n/a |
10 | chr2:74010290-74010340 | PANC-1 | pancreas: | n/a |
11 | chr2:74010396-74010446 | HCPEpiC | choroid plexus: | n/a |
12 | chr2:74010290-74010340 | IMR90 | lung: | fetal |
13 | chr2:74010554-74010604 | HCPEpiC | choroid plexus: | n/a |
14 | chr2:74010290-74010340 | HNPCEpiC | eye: | n/a |
15 | chr2:74010621-74010671 | CMK | blood: | n/a |
16 | chr2:74010396-74010446 | AG09319 | gingival: | n/a |
17 | chr2:74010554-74010604 | HRPEpiC | eye: | n/a |
18 | chr2:74010554-74010604 | K562 | blood: | n/a |
19 | chr2:74010554-74010604 | GM12892 | blood: | n/a |
20 | chr2:74010290-74010340 | H1-hESC | embryonic stem cell: | embryo |
21 | chr2:74010396-74010446 | SK-N-SH | brain: | n/a |
22 | chr2:74010396-74010446 | Hepatocyte | liver: | n/a |
23 | chr2:74010554-74010604 | HPAEpiC | pulmonary alveolar: | n/a |
24 | chr2:74010554-74010604 | HNPCEpiC | eye: | n/a |
25 | chr2:74010621-74010671 | SKMC | muscle: | n/a |
26 | chr2:74010621-74010671 | HCF | heart: | n/a |
27 | chr2:74010554-74010604 | RPTEC | kidney: | n/a |
28 | chr2:74010554-74010604 | NHBE | bronchial: | n/a |
29 | chr2:74010554-74010604 | BJ | skin: | n/a |
30 | chr2:74010621-74010671 | NT2-D1 | testis: | n/a |
31 | chr2:74010396-74010446 | SAEC | small airway: | n/a |
32 | chr2:74010396-74010446 | HAEpiC | amniotic membrane: | n/a |
33 | chr2:74010290-74010340 | GM12891 | blood: | n/a |
34 | chr2:74010396-74010446 | MCF10A-Er-Src | breast: | n/a |
35 | chr2:74010554-74010604 | PrEC | prostate: | n/a |
36 | chr2:74010621-74010671 | HCT-116 | colon: | n/a |
37 | chr2:74010290-74010340 | ProgFib | skin: | n/a |
38 | chr2:74010621-74010671 | PFSK-1 | brain: | n/a |
39 | chr2:74010290-74010340 | SK-N-MC | brain: | n/a |
40 | chr2:74010621-74010671 | HepG2 | liver: | n/a |
41 | chr2:74010290-74010340 | GM12892 | blood: | n/a |
42 | chr2:74010621-74010671 | PANC-1 | pancreas: | n/a |
43 | chr2:74010396-74010446 | IMR90 | lung: | fetal |
44 | chr2:74010621-74010671 | U87 | brain: | n/a |
45 | chr2:74010290-74010340 | GM19239 | blood: | n/a |
46 | chr2:74010396-74010446 | HMEC | breast: | n/a |
47 | chr2:74010290-74010340 | SAEC | small airway: | n/a |
48 | chr2:74010554-74010604 | Hela-S3 | cervix: | n/a |
49 | chr2:74010554-74010604 | U87 | brain: | n/a |
50 | chr2:74010554-74010604 | HCM | heart: | n/a |
No data |
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
DUSP11 | TF binding region |
C2orf78 | TF binding region |
DUSP11 | CpG island |
C2orf78 | CpG island |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs576757137 | chr2:74010154-74010155 | Enhancers Weak transcription Flanking Active TSS | TF binding region | 2 gene(s) | Overlapped CNVs | n/a |
2 | rs548635162 | chr2:74010155-74010156 | Enhancers Weak transcription Flanking Active TSS | TF binding region | 2 gene(s) | Overlapped CNVs | n/a |
3 | rs190420297 | chr2:74010165-74010166 | Enhancers Weak transcription Flanking Active TSS | TF binding region | 2 gene(s) | Overlapped CNVs | n/a |
4 | rs531055385 | chr2:74010193-74010194 | Enhancers Weak transcription Flanking Active TSS | TF binding region | 2 gene(s) | Overlapped CNVs | n/a |
5 | rs552805490 | chr2:74010207-74010208 | Flanking Active TSS Weak transcription Enhancers Flanking Bivalent TSS/Enh | TF binding region | 2 gene(s) | Overlapped CNVs | n/a |
6 | rs570916143 | chr2:74010220-74010221 | Flanking Active TSS Weak transcription Enhancers Flanking Bivalent TSS/Enh | TF binding region | 2 gene(s) | Overlapped CNVs | n/a |
7 | rs181559778 | chr2:74010227-74010228 | Flanking Active TSS Weak transcription Enhancers Flanking Bivalent TSS/Enh | TF binding region | 2 gene(s) | Overlapped CNVs | n/a |
8 | rs553383297 | chr2:74010243-74010244 | Flanking Active TSS Weak transcription Enhancers Flanking Bivalent TSS/Enh | TF binding region | 2 gene(s) | Overlapped CNVs | n/a |
9 | rs2685277 | chr2:74010265-74010266 | Flanking Active TSS Weak transcription Enhancers Flanking Bivalent TSS/Enh | TF binding region | 2 gene(s) | Overlapped CNVs | mRNA abundance |
10 | rs536540777 | chr2:74010290-74010291 | Flanking Active TSS Weak transcription Enhancers Flanking Bivalent TSS/Enh | TF binding regionCpG island | 2 gene(s) | Overlapped CNVs | n/a |
11 | rs185732010 | chr2:74010293-74010294 | Flanking Active TSS Weak transcription Enhancers Flanking Bivalent TSS/Enh | TF binding regionCpG island | 2 gene(s) | Overlapped CNVs | n/a |
12 | rs145481924 | chr2:74010305-74010306 | Flanking Active TSS Weak transcription Enhancers Flanking Bivalent TSS/Enh | TF binding regionCpG island | 2 gene(s) | Overlapped CNVs | n/a |
13 | rs543174942 | chr2:74010306-74010307 | Flanking Active TSS Weak transcription Enhancers Flanking Bivalent TSS/Enh | TF binding regionCpG island | 2 gene(s) | Overlapped CNVs | n/a |
14 | rs556647091 | chr2:74010327-74010328 | Flanking Active TSS Weak transcription Enhancers Flanking Bivalent TSS/Enh | TF binding regionCpG island | 2 gene(s) | Overlapped CNVs | n/a |
15 | rs190050800 | chr2:74010359-74010360 | Flanking Active TSS Weak transcription Enhancers Flanking Bivalent TSS/Enh | TF binding region | 2 gene(s) | Overlapped CNVs | n/a |
16 | rs540754309 | chr2:74010387-74010388 | Flanking Active TSS Weak transcription Enhancers Flanking Bivalent TSS/Enh | TF binding region | 2 gene(s) | Overlapped CNVs | n/a |
17 | rs577101243 | chr2:74010397-74010398 | Flanking Active TSS Weak transcription Enhancers Flanking Bivalent TSS/Enh | TF binding regionCpG island | 2 gene(s) | Overlapped CNVs | n/a |
18 | rs148898923 | chr2:74010405-74010406 | Flanking Active TSS Enhancers Bivalent/Poised TSS | TF binding regionCpG island | 2 gene(s) | Overlapped CNVs | n/a |
19 | rs529697192 | chr2:74010415-74010416 | Flanking Active TSS Enhancers Bivalent/Poised TSS | TF binding regionCpG island | 2 gene(s) | Overlapped CNVs | n/a |
20 | rs112200759 | chr2:74010438-74010439 | Flanking Active TSS Enhancers Bivalent/Poised TSS | TF binding regionCpG island | 2 gene(s) | Overlapped CNVs | n/a |
21 | rs148024891 | chr2:74010443-74010444 | Flanking Active TSS Enhancers Bivalent/Poised TSS | TF binding regionCpG island | 2 gene(s) | Overlapped CNVs | n/a |
22 | rs531239080 | chr2:74010451-74010452 | Flanking Active TSS Enhancers Bivalent/Poised TSS | TF binding region | 2 gene(s) | Overlapped CNVs | n/a |
23 | rs142571969 | chr2:74010461-74010462 | Flanking Active TSS Enhancers Bivalent/Poised TSS | TF binding region | 2 gene(s) | Overlapped CNVs | n/a |
24 | rs182362110 | chr2:74010519-74010520 | Flanking Active TSS Enhancers Bivalent/Poised TSS | TF binding region | 2 gene(s) | Overlapped CNVs | n/a |
25 | rs185936003 | chr2:74010522-74010523 | Flanking Active TSS Enhancers Bivalent/Poised TSS | TF binding region | 2 gene(s) | Overlapped CNVs | n/a |
26 | rs546822512 | chr2:74010533-74010534 | Flanking Active TSS Enhancers Bivalent/Poised TSS | TF binding region | 2 gene(s) | Overlapped CNVs | n/a |
27 | rs568441448 | chr2:74010544-74010545 | Flanking Active TSS Enhancers Bivalent/Poised TSS | TF binding region | 2 gene(s) | Overlapped CNVs | n/a |
28 | rs535435192 | chr2:74010555-74010556 | Flanking Active TSS Enhancers Bivalent/Poised TSS | TF binding regionCpG island | 2 gene(s) | Overlapped CNVs | n/a |
29 | rs190705912 | chr2:74010566-74010567 | Flanking Active TSS Enhancers Bivalent/Poised TSS | TF binding regionCpG island | 2 gene(s) | Overlapped CNVs | n/a |
30 | rs114036610 | chr2:74010577-74010578 | Flanking Active TSS Enhancers Bivalent/Poised TSS | TF binding regionCpG island | 2 gene(s) | Overlapped CNVs | n/a |
31 | rs536971908 | chr2:74010579-74010580 | Flanking Active TSS Enhancers Bivalent/Poised TSS | TF binding regionCpG island | 2 gene(s) | Overlapped CNVs | n/a |
32 | rs79364027 | chr2:74010587-74010588 | Flanking Active TSS Enhancers Bivalent/Poised TSS | TF binding regionCpG island | 2 gene(s) | Overlapped CNVs | n/a |
33 | rs13006598 | chr2:74010592-74010593 | Flanking Active TSS Enhancers Bivalent/Poised TSS | TF binding regionCpG island | 2 gene(s) | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
34 | rs540715277 | chr2:74010593-74010594 | Flanking Active TSS Enhancers Bivalent/Poised TSS | TF binding regionCpG island | 2 gene(s) | Overlapped CNVs | n/a |
35 | rs12466586 | chr2:74010595-74010596 | Flanking Active TSS Enhancers Bivalent/Poised TSS | TF binding regionCpG island | 2 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
36 | rs559876239 | chr2:74010601-74010602 | Active TSS Enhancers | TF binding regionCpG island | 2 gene(s) | Overlapped CNVs | n/a |
37 | rs188746972 | chr2:74010609-74010610 | Active TSS Enhancers | TF binding region | 2 gene(s) | Overlapped CNVs | n/a |
38 | rs541419538 | chr2:74010613-74010614 | Active TSS Enhancers | TF binding region | 2 gene(s) | Overlapped CNVs | n/a |
39 | rs563308654 | chr2:74010622-74010623 | Active TSS Enhancers | TF binding regionCpG island | 2 gene(s) | Overlapped CNVs | n/a |
40 | rs575989395 | chr2:74010628-74010629 | Active TSS Enhancers | TF binding regionCpG island | 2 gene(s) | Overlapped CNVs | n/a |
41 | rs558961722 | chr2:74010629-74010630 | Active TSS Enhancers | TF binding regionCpG island | 2 gene(s) | Overlapped CNVs | n/a |
42 | rs564662875 | chr2:74010669-74010670 | Active TSS Enhancers | TF binding regionCpG island | 2 gene(s) | Overlapped CNVs | n/a |
43 | rs192140542 | chr2:74010675-74010676 | Active TSS Enhancers | TF binding region | 2 gene(s) | Overlapped CNVs | n/a |
44 | rs527488506 | chr2:74010676-74010677 | Active TSS Enhancers | TF binding region | 2 gene(s) | Overlapped CNVs | n/a |
45 | rs561999993 | chr2:74010682-74010683 | Active TSS Enhancers | TF binding region | 2 gene(s) | Overlapped CNVs | n/a |
46 | rs182726054 | chr2:74010700-74010701 | Active TSS Enhancers | TF binding region | 2 gene(s) | Overlapped CNVs | n/a |
47 | rs375452763 | chr2:74010710-74010711 | Active TSS Enhancers | TF binding region | 2 gene(s) | Overlapped CNVs | n/a |
48 | rs550673782 | chr2:74010715-74010716 | Active TSS Enhancers | TF binding region | 2 gene(s) | Overlapped CNVs | n/a |
49 | rs568937325 | chr2:74010726-74010727 | Active TSS Enhancers | TF binding region | 2 gene(s) | Overlapped CNVs | n/a |
50 | rs536930698 | chr2:74010730-74010731 | Active TSS Enhancers | TF binding region | 2 gene(s) | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Chronic lymphocytic leukemia | 21546498 | CNVD |
Diffuse large b-cell lymphoma | 18287131 | CNVD |
Ovarian neoplasms | 16753589 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Neuroblastoma | 17533364 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Adrenal tumor | 17535989 | CNVD |
Breast cancer | 21264507 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Medulloblastoma | 17522785 | CNVD |
Cancer | 23418310 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Breast cancer | 17603634 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Ependymoma | 16718352 | CNVD |
Prostate cancer | 18632612 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Intellectual disability | 22102821 | CNVD |
Cancer | 20164919 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Follicular lymphoma | 20505157 | CNVD |
Autism | 17483303 | CNVD |
Myofibroblastic sarcoma | 19369631 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Esophageal adenocarcinoma | 18519675 | CNVD |
Medulloblastoma | 20607354 | CNVD |
Autism | 22495311 | CNVD |
Autism | 18522746 | CNVD |
Lung cancer | 18438408 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
Melanoma | 18172304 | CNVD |
Cancer | 16751803 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Developmental delay | 21147756 | CNVD |
Carcinoma ex pleomorphic adenoma | 18828159 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Seminomas | 18059402 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Invasive pancreatic ductal carcinoma | 16982739 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Renal cell carcinoma | 18765545 | CNVD |
Myxofibrosarcoma | 16751306 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Breast cancer | 22522925 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr2:74007400-74010400 | Weak transcription | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
2 | chr2:74007600-74010200 | Weak transcription | Foreskin Keratinocyte Primary Cells skin02 | Skin |
3 | chr2:74007800-74010200 | Weak transcription | A549 | lung |
4 | chr2:74010000-74010200 | Enhancers | ES-I3 Cell Line | embryonic stem cell |
5 | chr2:74010000-74010200 | Flanking Active TSS | HepG2 | liver |
6 | chr2:74010000-74010400 | Enhancers | HUES6 Cell Line | embryonic stem cell |
7 | chr2:74010000-74010600 | Enhancers | NHEK | skin |
8 | chr2:74010000-74010800 | Enhancers | Foreskin Keratinocyte Primary Cells skin03 | Skin |
9 | chr2:74010000-74010800 | Enhancers | Hela-S3 | cervix |
10 | chr2:74010000-74011000 | Enhancers | HMEC | breast |
11 | chr2:74010200-74010400 | Enhancers | A549 | lung |
12 | chr2:74010200-74010400 | Flanking Bivalent TSS/Enh | HepG2 | liver |
13 | chr2:74010200-74010600 | Flanking Active TSS | ES-I3 Cell Line | embryonic stem cell |
14 | chr2:74010200-74010800 | Enhancers | Foreskin Keratinocyte Primary Cells skin02 | Skin |
15 | chr2:74010400-74010600 | Flanking Active TSS | A549 | lung |
16 | chr2:74010400-74010600 | Bivalent/Poised TSS | HepG2 | liver |
17 | chr2:74010400-74010800 | Enhancers | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
18 | chr2:74010600-74011000 | Active TSS | ES-I3 Cell Line | embryonic stem cell |
19 | chr2:74010600-74011000 | Active TSS | A549 | lung |
20 | chr2:74010600-74011000 | Active TSS | HepG2 | liver |